Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2006-03-28
2006-03-28
Azpuru, Carlos A (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C424S078040
Reexamination Certificate
active
07018646
ABSTRACT:
A flat strip of supporting material, such as filter paper, having marked reference locations on each of one or more legs, for delivering controlled quantities of one or more agents to the adnexa of the eye simultaneously upon dispensing a liquid to the strip at the appropriate reference location.
REFERENCES:
patent: 3075527 (1963-01-01), Bechtold
patent: 3306820 (1967-02-01), Krezanoski
patent: 3911098 (1975-10-01), Capozza
patent: 4179497 (1979-12-01), Cohen
patent: 4341223 (1982-07-01), Lutz
patent: 4350676 (1982-09-01), Laties
patent: 4540408 (1985-09-01), Lloyd
patent: 4946450 (1990-08-01), Erwin
patent: 4951683 (1990-08-01), Davis
patent: 5170799 (1992-12-01), Nagase et al.
patent: 5314419 (1994-05-01), Pelling
patent: 5320845 (1994-06-01), Py
patent: 5433714 (1995-07-01), Bloomberg
patent: 5462739 (1995-10-01), Dan
patent: 5472436 (1995-12-01), Fremstad
patent: 5928662 (1999-07-01), Phillips
patent: 5944702 (1999-08-01), Py
patent: 5981607 (1999-11-01), Ding
patent: 6027745 (2000-02-01), Nakada
patent: 6030974 (2000-02-01), Schwartz
patent: 6054485 (2000-04-01), Schwartz
patent: 6106930 (2000-08-01), Ludwig
patent: 6159188 (2000-12-01), Laibovitz
patent: 6218428 (2001-04-01), Chynn
patent: 6228381 (2001-05-01), Suvenkrup
patent: 6306120 (2001-10-01), Tan
Snyder C, Paugh Jr. 1998 May;Rose bengal dye concentration and volume delivered via dye-impregnated paper strips 75(5):339-41 Optom Vis Sci.
Hogan RN, and Zimmerman CF. Sodium fluorescein and other tissue dyes Textbook of Ocular Pharmacology. Zimmerman, TJ, Kooner, KS, Sharir M, Fechtner RD, Editors (cont'd) Chapter 73 Dyes on strips—p. 850 NY: Lippincott—Raven Press, 1997.
Lawrenson JG, Edgar DF, Gudgeon AC, Burns JM, Geraint M, Barnard NA. A comparison of the efficacy and duration of action of topically applied proxymetacian using a novel (cont'd) ophthalmic delivery system versus eye drops in healthy young volunterrs Nov;77(11):713-5.
Diestelhorst M, Krieglstein GK The ocular tolerability of a new ophthalmic drug delivery system (NODS) 18(1):1-4 Int Ophthalmol 1994.
Diestelhorst M. Grunthal S, Suverkrup R. Dry Drops: a new perservative-free drug delivery system. 237(5):394-8 Graefes Arch Clin Exp Ophthalmol May 1999.
Alani SD. The ophthalmic rod—description of a disposable opthalmic drug delivery device15(3):237-40 Acta Pharm Suec 1978.
Alani SD. The ophthalmic rod: a new ophthalmic drug delivery systemII. 228(4):297-301 Clin Exp Ophthalmol 1990a.
Alani SD,Hammertein W. The ophthalmic rod—a new drug-delivery system II. 228(4):302-4 Arch Clin Exp Ophthalmol 1990b.
Gwon A, Borrmann LR, Duzman E. Robbins DS, Shen D. Ophthalmic rods. New ocular drug delivery device. 93(9suppl): 82-5.
Duane TD, and Jaefer EA, (editors) Records RE “Tear Film” in Biomedical Foundations of Ophthalmology, vol. 2, chapter 3, p. 1 Philadelphia: Harper and Row 1983.
Azpuru Carlos A
Etherton Sandra L.
Etherton Law Group, LLC
LandOfFree
Apparatus and method for delivering controlled quantities of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apparatus and method for delivering controlled quantities of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apparatus and method for delivering controlled quantities of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3566810